SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
cea12233-sup-0001-FigS1.pdfapplication/PDF4KFigure S1. Kaplan–Meier estimate of survival, which represents the percentage of children who still suffer from dose-related reactions at each time interval while on oral immunotherapy (OIT).
cea12233-sup-0002-FigS2.pdfapplication/PDF4KFigure S2. Kaplan–Meier estimate of survival, showing the percentage of children who still suffer from dose-related reactions at each time interval while on-OIT, stratified by reactions severity at baseline double-blind placebo-controlled food challenge (DBPCFC) [21]
cea12233-sup-0003-TableS1.docWord document46KTable S1. Univariate logistic regression analysis, showing baseline risk factors for belonging to subgroup RR (children who stop reacting to egg-OIT doses over time) as opposed to subgroups PR (children with ongoing reactions over the whole period on-OIT) and ED (children requiring early OIT discontinuation due to frequent reactions not improved by medication or protocol re-adaptation).

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.